Cargando…

Carbohydrate antigen 19-9 — tumor marker: Past, present, and future

Carbohydrate antigen 19-9 (CA 19-9) is a cell surface glycoprotein complex most commonly associated with pancreatic ductal adenocarcinoma (PDAC). Koprowski first described it in 1979 using a mouse monoclonal antibody in a colorectal carcinoma cell line. Historically, it is one of the most commonly u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tsinrong, Teng, Thomas Zheng Jie, Shelat, Vishal G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769746/ https://www.ncbi.nlm.nih.gov/pubmed/33437400 http://dx.doi.org/10.4240/wjgs.v12.i12.468

Ejemplares similares

Choledochoscopy: An update
por: Lee, Tsinrong, et al.
Publicado: (2021)

Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
por: Kim, Jaihwan, et al.
Publicado: (2015)

Antigen Delivery Systems: Past, Present, and Future
por: Ko, Hyun-Jeong, et al.
Publicado: (2023)

Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections
por: Galili, Uri
Publicado: (2020)

Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer
por: Lee, Jong-Chan, et al.
Publicado: (2013)

The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer.
por: McKnight, A., et al.
Publicado: (1989)

Persistent High Level of Urinary Tumor Marker Carbohydrate Antigen 19-9 in Prenatally Diagnosed Dysplastic Kidney
por: Khorramirouz, Reza, et al.
Publicado: (2014)

Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers
por: Liu, Hai-Ning, et al.
Publicado: (2023)

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Diagnostic, Prognostic and Predictive Markers in Pediatric Germ Cell Tumors—Past, Present and Future
por: Jezierska, Michalina, et al.
Publicado: (2022)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Ferroptosis: past, present and future
por: Li, Jie, et al.
Publicado: (2020)

Carbohydrate based meningococcal vaccines: past and present overview
por: Berti, Francesco, et al.
Publicado: (2021)

Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor
por: Shimizu, Yuki, et al.
Publicado: (2021)

Usefulness of Carbohydrate Antigen 19-9 Test in Healthy People and Necessity of Medical Follow-up in Individuals with Elevated Carbohydrate Antigen 19-9 Level
por: Lee, Sang Pyo, et al.
Publicado: (2019)

Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.
por: Kew, M. C., et al.
Publicado: (1987)

Past, present and future
Publicado: (1982)

Past, present and future
Publicado: (2000)

Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cancer Antigen 125, Prostate-Specific Antigen and Other Cancer Markers: A Primer on Commonly Used Cancer Markers
por: Desai, Shreya, et al.
Publicado: (2023)

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
por: Komarnicki, Paweł, et al.
Publicado: (2022)

Over-the-Counter Biosensors: Past, Present, and Future
por: Lee, Thomas Ming-Hung
Publicado: (2008)

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
por: Fujiwara, Yuki, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
por: Srour, Samer A., et al.
Publicado: (2022)

History of burns: The past, present and the future
por: Lee, Kwang Chear, et al.
Publicado: (2014)

Vasoplegia treatments: the past, the present, and the future
por: Levy, Bruno, et al.
Publicado: (2018)

Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer
por: Kang, Jae Seung, et al.
Publicado: (2021)

Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder
por: Agrawal, Saumya, et al.
Publicado: (2020)

Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas
por: Qian, Yunzhen, et al.
Publicado: (2022)

Cartography past, present and future
por: Rhind, DW, et al.
Publicado: (2013)

The LHC: Past, Present and Future
por: Tovey, D R
Publicado: (2014)

Climate: present, past and future
por: Lamb, H. H.
Publicado: (1972)

PEComas: the past, the present and the future
por: Martignoni, Guido, et al.
Publicado: (2007)

Imaging, past present and future.
por: McIlrath, E. M.
Publicado: (1998)

Diabetes: Past, Present and Future
por: Smyth, J. A.
Publicado: (1954)

Resuscitation in the past, the present and the future.
por: Adgey, A. A. Jennifer
Publicado: (2002)

Infiniband: Past, Present and Future
por: Haviv, Yaron
Publicado: (2004)

LEAR, past, present and future
por: Lefèvre, P
Publicado: (1989)

Plague: Past, Present, and Future
por: Stenseth, Nils Chr, et al.
Publicado: (2008)

Misdirection – Past, Present, and the Future
por: Kuhn, Gustav, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_npmth7leb23jql9i4rmgb75ttj